Table 3.
Prevalence of osteoporosis and osteopenia in postmenopausal women receiving lumbar epidural injections.
| Non-DM group (n = 86) | DM group (n = 86) | |||
|---|---|---|---|---|
| Baseline | 1-year F/U | Baseline | 1-year F/U | |
| Lumbar spine | ||||
| Normal | 15 (17%) | 13 (15%) | 12 (14%) | 13 (15%) |
| Osteopenia | 37 (43%) | 38 (44%) | 38 (44%) | 39 (45%) |
| Osteoporosis | 34 (40%) | 35 (41%) | 36 (42%) | 34 (40%) |
|
| ||||
| Total femur | ||||
| Normal | 19 (22%) | 19 (22%) | 19 (22%) | 17 (20%) |
| Osteopenia | 48 (56%) | 44 (51%) | 43 (50%) | 48 (56%) |
| Osteoporosis | 19 (22%) | 23 (27%) | 24 (28%) | 21 (24%) |
|
| ||||
| Femoral neck | ||||
| Normal | 14 (16%) | 13 (15%) | 10 (12%) | 10 (12%) |
| Osteopenia | 50 (58%) | 50 (58%) | 51 (59%) | 50 (58%) |
| Osteoporosis | 22 (26%) | 23 (27%) | 25 (29%) | 26 (30%) |
Values represent the number of patients (%). The non-DM group consisted of postmenopausal women without diabetes mellitus who received ESI. The DM group consisted of postmenopausal women with diabetes mellitus who received ESI. There were no significant differences in follow-up BMD outcomes between the groups. Bone mineral density data are based on T-scores. Osteopenia was defined as −2.5 SD < BMD T score < −1.0 SD. Osteoporosis was defined as BMD T-score ≤ −2.5 SD. BMD = bone mineral density; ESI = epidural steroid injection; F/U = follow-up.